PHE's Health Economics Evidence Resource was produced to help local areas access the evidence they need to make evidence-based investment decisions. It has now been updated with over 100 interventions added and to include evidence from some of the latest health economics sources.
Brian joined PHE in April 2013 having previously been Director of the Yorkshire & Humber Public Health and Quality Observatories since 2004, and Co-Director of the Northern and Yorkshire Cancer Registry & Information Service since April 2010. Brian was Chair of the UK & Ireland Association of PHOs from April 2006 to March 2011. Within PHE Brian was interim national Director of Knowledge and Intelligence between October 2013 and March 2015. He is now Chief Economist for PHE.
Brian has previously held posts as Deputy Director of the Centre for Health Economics, University of York, and was the founding Professor of Health Economics in the University of Leeds. He was a member of the National Public Health Career Scientist Award Panel for five years and was a PCT non-executive director for four years. Brian was a member of NICE’s Public Health Interventions Advisory Committee from 2005-08, and was a member of the Programme Advisory Board of the NIHR Public Health Research Programme between 2009-14. Brian has chaired the Research Advisory Committee of the National Diabetic Eye Screening Programme since 2011. He is a member of the International Editorial Board for the journal Public Health. Brian was admitted to the UK Public Health Register in February 2007.
Does an ageing population lead to higher costs for the NHS and social care? Find out why this is not necessarily a foregone conclusion.
In the recent launch teleconference of the latest edition of Health Matters – on the subject of ‘Health Economics and making the most of your budget’ – we had a range of important questions on PHE’s Health Economics tools from professionals across the UK. This blog summarises the main topics that were covered.
The human costs of smoking, drinking too much alcohol and an unhealthy diet are widely known, with consequences ranging from heart disease and type 2 diabetes through to many types of cancer.
Evidence shows that prevention and early intervention don’t simply tackle the human cost of ill health, they also represent good value for money, reduce demand on public services and support economic growth.
PHE's Spend and Outcome Tool allows users to see how much is being spent and the impact it is having on relevant outcomes, meaning they can compare across public health programmes, and compare these data against other local authorities.
An urgent and costly public health problem During the 1950s, smog (a toxic combination of soot and sulphur dioxide) was commonplace in UK cities and a major source of disease. Since the Clean Air Act of 1956, the character of …
In leading PHE’s Health Economics team it’s my job to make the economic case for public health, whether that’s providing return on investment tools for local government and the NHS, or working with national government to discuss the wider impact …
We've published a new ‘Prioritisation Framework’, a strategic planning resource for local authorities. In this blog, our Chief Economist Brian Ferguson, and PHE North East Centre Director Peter Kelly, answer questions about how the Framework can inform investment decisions. What …
Musculoskeletal (MSK) conditions, such as osteoarthritis hip and knee, back pain and neck pain have a huge negative impact on the health of the population.